Otsuka Pharmaceutical will pay
approximately $3.5 billion in cash to acquire Avanir Pharmaceuticals
Inc. (Nasdaq: AVNR) sending the stock price up $1.92 to close at $16.92.
Avanir to be acquired
December 02, 2014 at 09:09 AM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.